ES2142005T3 - Formulacion de lanperisona. - Google Patents

Formulacion de lanperisona.

Info

Publication number
ES2142005T3
ES2142005T3 ES96115516T ES96115516T ES2142005T3 ES 2142005 T3 ES2142005 T3 ES 2142005T3 ES 96115516 T ES96115516 T ES 96115516T ES 96115516 T ES96115516 T ES 96115516T ES 2142005 T3 ES2142005 T3 ES 2142005T3
Authority
ES
Spain
Prior art keywords
lanperisone
formulation
hydrochloride
suction
granules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96115516T
Other languages
English (en)
Inventor
Hiroshi Ohtaki
Rie Joshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Application granted granted Critical
Publication of ES2142005T3 publication Critical patent/ES2142005T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FORMULACION MOLDEADA POR COMPRESION DE HIDROCLORURO DE LANPERISONA QUE INCLUYE UNOS PRIMEROS GRANULOS QUE CONTIENEN HIDROCLORURO DE LANPERISONA Y UNOS SEGUNDOS GRANULOS QUE BASICAMENTE CONTIENEN EN LUGAR DE CLORURO DE LANPERISONA AL MENOS UN ADITIVO-S FARMACEUTICO-S SELECCIONADO-S A PARTIR DEL GRUPO INTEGRADO POR GLUCOSAS, CELULOSAS CRISTALINAS Y DERIVADOS DE CELULOSA; CONVIRTIENDOSE EN UNA FORMULACION EXCELENTE CON UNA ALTA ESTABILIDAD DE ALMACENAMIENTO DEBIDA A LA SUPRESION DE LA DESCOMPOSICION DE HIDROCLORURO DE LANPERISONA.
ES96115516T 1995-10-06 1996-09-27 Formulacion de lanperisona. Expired - Lifetime ES2142005T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28434295 1995-10-06

Publications (1)

Publication Number Publication Date
ES2142005T3 true ES2142005T3 (es) 2000-04-01

Family

ID=17677343

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96115516T Expired - Lifetime ES2142005T3 (es) 1995-10-06 1996-09-27 Formulacion de lanperisona.

Country Status (7)

Country Link
US (1) US5843478A (es)
EP (1) EP0770386B1 (es)
KR (1) KR970020105A (es)
DE (1) DE69606487T2 (es)
ES (1) ES2142005T3 (es)
HU (1) HUP9602732A3 (es)
TW (1) TW434030B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999008526A1 (en) * 1997-08-21 1999-02-25 Eli Lilly And Company Methods for inhibiting temporomandibular disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944371A (ja) * 1982-09-07 1984-03-12 Dainippon Pharmaceut Co Ltd １―フエニル―２―メチル―３―（１―ピロリジニル）―１―プロパノン誘導体
ES8706598A1 (es) * 1985-04-11 1987-07-01 Nippon Kayaku Kk Un procedimiento para preparar nuevos derivados de aminocetona
KR940003292B1 (ko) * 1986-10-09 1994-04-20 닛뽕 가야꾸 가부시기가이샤 광학적 활성 2-메틸-1-(4-트리플루오로메틸페닐)-3-피롤리디노-1-프로파논 및 그 제조방법
JP2711776B2 (ja) * 1991-07-16 1998-02-10 日本化薬株式会社 顎関節症治療剤

Also Published As

Publication number Publication date
TW434030B (en) 2001-05-16
KR970020105A (ko) 1997-05-28
DE69606487D1 (de) 2000-03-09
EP0770386A1 (en) 1997-05-02
US5843478A (en) 1998-12-01
DE69606487T2 (de) 2000-07-13
HUP9602732A2 (en) 1997-09-29
HU9602732D0 (en) 1996-11-28
HUP9602732A3 (en) 2000-09-28
EP0770386B1 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
ES2065984T3 (es) Composicion detergente que contiene un perfume.
ATE203546T1 (de) Lagerstabile hämoglobinlösungen
JO1969B1 (en) Granulation process for the preparation of rapidly dissolving and dissolving compounds containing a high amount of the drug
PT96330A (pt) Processo de preparacao de preparados contendo l-tartarato de l-carnitina
EP0204942A3 (en) Compiler for a source program, a method of making the same and its use
ES2162297T3 (es) Dispositivo y procedimiento para la regulacion de la presion del combustible en un acumulador de alta presion.
CA2239174A1 (en) Novel compounds with analgesic effect
WO2000011971A3 (en) Fiber and vitamin-fortified beverage
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
ES2150438T3 (es) Composicion de esferonizacion a base de celulosa microcristalina.
GEP20012390B (en) Benzonaphthyridines as Bronchial Therapeutics
ES2185789T3 (es) Laxante que contiene lactitol y psilio.
ES2098902T3 (es) Composicion limpiadora y blanqueadora con amidoperoxiacido.
IL145187A0 (en) Echinocandin/carbohydrate complexes
ES2046852T3 (es) Un procedimiento para preparar un champu.
ES2081978T3 (es) Un virus de polihedrosis nuclear con incorporacion multiple de la oruga del apio con actividad contra los lepidopteros.
ES2176792T3 (es) Tabletas que contienen una resina de intercambio ionico.
MY121421A (en) Shock absorber
EA200100947A1 (ru) Жевательные таблетки с высоким содержанием n-ацетилцистеина
CA2061995A1 (en) Use of oxime ether derivatives for bioregulation in plants
ES2061829T3 (es) Solucion acuosa, estable frente al almacenamiento, de alquiltrialcoxisilanos.
ES2149736T1 (es) Composiciones farmaceuticas conteniendo derivados de tienopiridina estables y libres de antioxidantes.
ES2138362T3 (es) Derivados de citisina con contenido de fosforo.
JPS6473434A (en) Address conversion device
DE69023241D1 (de) Ionophore enthaltende abgabevorrichtung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 770386

Country of ref document: ES